BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17320306)

  • 1. Potential therapeutic implications of intracrine angiogenesis.
    Re RN; Cook JL
    Med Hypotheses; 2007; 69(2):414-21. PubMed ID: 17320306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic growth factors and their inhibitors in diabetic retinopathy.
    Praidou A; Androudi S; Brazitikos P; Karakiulakis G; Papakonstantinou E; Dimitrakos S
    Curr Diabetes Rev; 2010 Sep; 6(5):304-12. PubMed ID: 20594164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: Intracrine physiology in the cardiovascular system.
    Re RN; Cook JL
    Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):549-57. PubMed ID: 17893683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
    Gacche RN; Meshram RJ
    Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in rheumatoid arthritis.
    Maruotti N; Cantatore FP; Crivellato E; Vacca A; Ribatti D
    Histol Histopathol; 2006 May; 21(5):557-66. PubMed ID: 16493585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of angiogenesis in tumors of the gastrointestinal tract.
    Reinmuth N; Parikh AA; Ahmad SA; Liu W; Stoeltzing O; Fan F; Takeda A; Akagi M; Ellis LM
    Microsc Res Tech; 2003 Feb; 60(2):199-207. PubMed ID: 12539174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiogenesis and hematologic malignancy].
    Zini JM; Tobelem G
    Bull Cancer; 2007 Jul; 94 Spec No():S241-6. PubMed ID: 17846010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in gliomas.
    Machein M; de Miguel LS
    Recent Results Cancer Res; 2009; 171():193-215. PubMed ID: 19322546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic therapies in cancer: achievements and open questions.
    Ruegg C; Mutter N
    Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intracrine view of angiogenesis.
    Re RN; Cook JL
    Bioessays; 2006 Sep; 28(9):943-53. PubMed ID: 16937366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E; Taher A
    J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
    Cao Y; Liu Q
    Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment.
    Rani V; Prabhu A
    Curr Pharm Des; 2021; 27(7):919-931. PubMed ID: 33006535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of apelin as a therapeutic target in cancer: a patent review.
    Rayalam S; Della-Fera MA; Kasser T; Warren W; Baile CA
    Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):367-72. PubMed ID: 21612576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.